Clinical Trial on Quality of Life, Cervical Cancer, Cervical Intraepithelial Neoplasia - Clinical Trials Registry

Study Overview

Status

Completed

Conditions

Detailed Description

In Thailand, age standardized incidence is 20.9 per 100,000 women-year. Treatment-related survival gain are experienced by side-effect that may reduce quality of life (QoL). We therefore, study the quality of life of patients earlier diagnosed for cervical cancer patients.

Study Type

Observational

Enrollment (Actual)

172

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Thailand
- Bangkok
  - Patumwan, Bangkok, Thailand, 10330
    - King Chulalongkorn Memorial Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

15 years to 85 years (Child, Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Sampling Method

Non-Probability Sample

Study Population

Cervical intraepithelial neoplasia (CIN) or cervical cancer patients

Description

Inclusion Criteria:

Thai patients
aged more than 15 years old.
Diagnosed of cervical intraepithelial neoplasia (CIN) or cervical cancer with pathological confirmation. If she has more than one diseases, the most severe will be considered as diagnosis.
Not suffered from confusion or reduced level of consciousness or unable to communicate.

Exclusion Criteria:

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Chulalongkorn University

Collaborators

Merck Sharp & Dohme LLC

Investigators

Principal Investigator: Surasak Taneepanichskul, MD., College of Public Health Sciences, Chulalongkorn University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

February 1, 2008

Primary Completion (Actual)

November 1, 2008

Study Completion (Actual)

July 1, 2009

Study Registration Dates

First Submitted

August 25, 2008

First Submitted That Met QC Criteria